Verthermia® has a heart for patients in hospice and is leading the way to provide hope for those for whom traditional therapies have not worked. With exciting results from two FDA phase 1 clinical trials which we believe show safety, and effectiveness in destroying lung and ovarian cancers, Verthermia® has developed a therapy to extend life and enhance the quality of daily living for those facing their last line of defense against cancer. As an eligible therapy to treat patients as a physician directed treatment or under the Right to Try Law, ®Verthermia’s application of whole-body hyperthermia via its patented system is opening doors for patients who are not ready to give up. Our partnership with First Baptist Medical Center, in Dallas, TX, allows access to HEATT® for eligible patients. Expansion into new partner institutions and clinical treatment facilities is on the horizon for early 2021 as we seek to support additional patients in their personal fight against cancer.
For the past 30+ years, Dr. Vertrees, founder and Chief Science Officer, and Dr. Joseph Zwishenberger, Chief Medical Officer of Verthermia®, have studied the impact of whole-body hyperthermia on the human body. Based on the century-old research of Wm. B. Coley who demonstrated that heat, properly applied, had therapeutic effects on tumors, they began experimenting with the impact of heat on cancer cells.
Dr. Vertrees devoted the next two decades to continued research, development of our patented system to safely deliver the therapy, and launched Verthermia® in 2012. Over the next few years, Dr. Vertrees put together the current clinical team, including Chief Clinical Officer Dr. Jan Winetz (partner in the development of our patented system), to conduct the Phase 1 Clinical Trial on Ovarian cancer.
With the addition of the current CEO, Mitchel May, in 2017, the path to increasing access of HEATT® to extend and enhance life for those for whom all other treatments have failed became reality. While for almost a century the science has been shown heat to be effective in destroying metastatic cancers, the technology was behind. With ®Verthermia’s researched therapy and patented system, technology has finally caught up to science!